KA
ABBV icon

Kovack Advisors’s AbbVie ABBV Stock Holding History

Kovack Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.62M Sell
22,380
-7,404
-25% -$1.59M 0.27% 72
2026
Q1 		$6.44M Sell
29,784
-1,095
-4% -$243K 0.34% 56
2025
Q4 		$7.06M Buy
30,879
+18,898
+158% +$4.3M 0.33% 66
2025
Q3 		$2.77M Sell
11,981
-3,229
-21% -$658K 0.26% 72
2025
Q2 		$2.82M Sell
15,210
-1,076
-7% -$200K 0.28% 74
2025
Q1 		$3.41M Sell
16,286
-662
-4% -$129K 0.36% 59
2024
Q4 		$3.01M Buy
16,948
+1,379
+9% +$254K 0.3% 64
2024
Q3 		$3.07M Sell
15,569
-282
-2% -$52.6K 0.33% 57
2024
Q2 		$2.72M Sell
15,851
-975
-6% -$162K 0.3% 69
2024
Q1 		$3.06M Buy
16,826
+2,327
+16% +$401K 0.37% 55
2023
Q4 		$2.25M Sell
14,499
-139
-0.9% -$20.3K 0.27% 79
2023
Q3 		$2.18M Sell
14,638
-204
-1% -$29.9K 0.3% 68
2023
Q2 		$2M Sell
14,842
-382
-3% -$56K 0.26% 79
2023
Q1 		$2.43M Buy
15,224
+288
+2% +$44K 0.33% 60
2022
Q4 		$2.41M Sell
14,936
-629
-4% -$96.4K 0.35% 57
2022
Q3 		$2.09M Sell
15,565
-5,443
-26% -$781K 0.31% 69
2022
Q2 		$3.22M Sell
21,008
-9,327
-31% -$1.43M 0.42% 47
2022
Q1 		$4.92M Buy
30,335
+1,714
+6% +$249K 0.51% 31
2021
Q4 		$3.88M Sell
28,621
-1,457
-5% -$172K 0.37% 51
2021
Q3 		$3.24M Buy
30,078
+5,229
+21% +$597K 0.35% 68
2021
Q2 		$2.8M Buy
24,849
+328
+1% +$36.9K 0.32% 80
2021
Q1 		$2.65M Sell
24,521
-631
-3% -$67.5K 0.34% 75
2020
Q4 		$2.69M Buy
25,152
+694
+3% +$66.7K 0.39% 57
2020
Q3 		$2.14M Buy
24,458
+7,152
+41% +$673K 0.38% 66
2020
Q2 		$1.7M Sell
17,306
-1,022
-6% -$90K 0.33% 78
2020
Q1 		$1.4M Sell
18,328
-6,074
-25% -$517K 0.32% 82
2019
Q4 		$2.16M Buy
24,402
+2,359
+11% +$196K 0.39% 65
2019
Q3 		$1.67M Buy
22,043
+8,461
+62% +$580K 0.34% 69
2019
Q2 		$988K Sell
13,582
-610
-4% -$47.9K 0.23% 111
2019
Q1 		$1.14M Sell
14,192
-480
-3% -$39.3K 0.29% 86
2018
Q4 		$1.35M Sell
14,672
-4,419
-23% -$389K 0.4% 67
2018
Q3 		$1.81M Buy
19,091
+2,818
+17% +$267K 0.47% 45
2018
Q2 		$1.51M Buy
16,273
+107
+0.7% +$10.4K 0.42% 51
2018
Q1 		$2.31M Sell
16,166
-2,286
-12% -$251K 0.58% 31
2017
Q4 		$1.67M Buy
18,452
+9,232
+100% +$870K 0.42% 50
2017
Q3 		$819K Sell
9,220
-3,594
-28% -$274K 0.27% 91
2017
Q2 		$929K Buy
12,814
+4,245
+50% +$285K 0.29% 73
2017
Q1 		$558K Sell
8,569
-293
-3% -$18.4K 0.22% 111
2016
Q4 		$555K Buy
8,862
+1,167
+15% +$71.2K 0.26% 88
2016
Q3 		$485K Sell
7,695
-692
-8% -$44.8K 0.24% 102
2016
Q2 		$519K Buy
8,387
+4,881
+139% +$297K 0.28% 86
2016
Q1 		$200K Buy
+3,506
New +$195K 0.13% 205
2015
Q4 		– Sell
-8,032
Closed -$437K – 238
2015
Q3 		$437K Buy
+8,032
New +$523K 0.3% 86

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Kovack Advisors's ABBV Position: Q2 2026 in Review

Kovack Advisors reduced its AbbVie (ABBV) stake by 25% in Q2 2026, selling an estimated $1.59M and leaving 22,380 shares worth $5.62M. The position accounts for 0.27% of the portfolio, ranked #72.

Kovack Advisors first reported a position in ABBV in Q3 2015 and has held it in 43 quarters since. The position peaked at $7.06M in Q4 2025. 1,855 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kovack Advisors held 22,380 shares of AbbVie worth $5.62M as of Q2 2026.
  • Kovack Advisors sold 7,404 AbbVie shares in Q2 2026, an estimated $1.59M.
  • AbbVie made up 0.27% of Kovack Advisors's portfolio in Q2 2026, its #72 holding.
  • Kovack Advisors first reported a position in AbbVie in Q3 2015 and has held it in 43 quarters since.
  • Kovack Advisors's AbbVie position peaked at $7.06M in Q4 2025.
  • 1,855 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.